Skip to main content
Equibles

RENAISSANCE TECHNOLOGIES LLC

Position in NUVB — Nuvation Bio Inc.

CIK 1037389 NEW YORK, NY
Back to NUVB Full portfolio

Position in NUVB

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$7,645,251
+$5,246,369 QoQ
Shares Held
1,345,995
+140.7% QoQ
Ownership
0.383%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#30
of 242 holders
Holding Since
Jun 2021
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NUVB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

RENAISSANCE TECHNOLOGIES LLC holds $3,950,489,724 across 311 Biotechnology names. NUVB ranks #65 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 EXEL
Exelixis, Inc.
 13,427,993 $730,617,099
2 CORT
Corcept Therapeutics Inc
 5,261,628 $457,498,554
3 INCY
Incyte Corp
 3,512,132 $398,135,283
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 320,008 $158,957,573
5 JAZZ
Jazz Pharmaceuticals plc
 562,073 $135,442,730
6 RPRX
Royalty Pharma plc
 1,935,800 $108,540,306
7 TVTX
Travere Therapeutics, Inc.
 1,833,079 $104,137,217
8 GMAB
Genmab A/S
 3,517,850 $96,635,339

All Filings in NUVB

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $7,645,251 1,345,995
2026-03-31 $2,398,882 559,180
2025-06-30 $43,095 22,100
2025-03-31 $781,616 444,100
2024-12-31 $1,507,688 566,800
2024-09-30 $2,356,410 1,029,000
2024-06-30 $2,222,120 761,000
2024-03-31 $3,547,908 974,700
2023-12-31 $2,239,527 1,483,131
2023-09-30 $522,600 390,000
2023-06-30 $561,420 311,900
2023-03-31 $453,346 273,100
2022-12-31 $276,864 144,200
2022-09-30 $583,553 260,515
2022-06-30 $279,612 86,300
2022-03-31 $484,972 92,200
2021-12-31 $421,600 49,600
2021-09-30 $500,976 50,400
2021-06-30 $4,345,908 466,800